PET scans in radiotherapy planning of lung cancer

Dirk De Ruysscher; Carl-Martin Kirsch

doi:10.1016/j.radonc.2010.07.002

PET scans in radiotherapy planning of lung cancer

Dirk De Ruysscher^*, Carl-Martin Kirsch

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

53 Citations (Web of Science)

Abstract

Especially for non-small cell lung cancer. FOG-PET has in the majority of the patients led to the safe decrease of radiotherapy volumes, enabling radiation-dose escalation and, experimentally, redistribution of radiation doses within the tumor. In limited-disease small cell lung cancer, the role of FDG-PET is emerging.

Original language	English
Pages (from-to)	335-338
Journal	Radiotherapy and Oncology
Volume	96
Issue number	3
DOIs	https://doi.org/10.1016/j.radonc.2010.07.002
Publication status	Published - Sep 2010

Keywords

Radiotherapy
PET
Lung cancer
Delineation
Target volumes

Access to Document

10.1016/j.radonc.2010.07.002

Cite this

@article{f429c836f9264fae8bccc8a20112b251,

title = "PET scans in radiotherapy planning of lung cancer",

abstract = "Especially for non-small cell lung cancer. FOG-PET has in the majority of the patients led to the safe decrease of radiotherapy volumes, enabling radiation-dose escalation and, experimentally, redistribution of radiation doses within the tumor. In limited-disease small cell lung cancer, the role of FDG-PET is emerging. ",

keywords = "Radiotherapy, PET, Lung cancer, Delineation, Target volumes",

author = "{De Ruysscher}, Dirk and Carl-Martin Kirsch",

year = "2010",

month = sep,

doi = "10.1016/j.radonc.2010.07.002",

language = "English",

volume = "96",

pages = "335--338",

journal = "Radiotherapy and Oncology",

issn = "0167-8140",

publisher = "Elsevier Ireland Ltd",

number = "3",

}

TY - JOUR

T1 - PET scans in radiotherapy planning of lung cancer

AU - De Ruysscher, Dirk

AU - Kirsch, Carl-Martin

PY - 2010/9

Y1 - 2010/9

N2 - Especially for non-small cell lung cancer. FOG-PET has in the majority of the patients led to the safe decrease of radiotherapy volumes, enabling radiation-dose escalation and, experimentally, redistribution of radiation doses within the tumor. In limited-disease small cell lung cancer, the role of FDG-PET is emerging.

AB - Especially for non-small cell lung cancer. FOG-PET has in the majority of the patients led to the safe decrease of radiotherapy volumes, enabling radiation-dose escalation and, experimentally, redistribution of radiation doses within the tumor. In limited-disease small cell lung cancer, the role of FDG-PET is emerging.

KW - Radiotherapy

KW - PET

KW - Lung cancer

KW - Delineation

KW - Target volumes

U2 - 10.1016/j.radonc.2010.07.002

DO - 10.1016/j.radonc.2010.07.002

M3 - Article

C2 - 20656364

VL - 96

SP - 335

EP - 338

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

SN - 0167-8140

IS - 3

ER -